A1C Level and Future Risk of Diabetes: A Systematic Review
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As with the glucose measures, several prospective studies that used A1C to predict the progression to diabetes as de fi ned by A1C criteria demonstrated a strong, continuous association between A1C and subsequent diabetes.”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those with an A1C range of 6.0 -6.5% (42 -48 mmol/mol) had a 5-year risk of developing diabetes between 25% and 50% and a relative risk 20 times higher than that with A1C of 5.0% (31 mmol/mol) (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that the risk of diabetes development on the basis of FPG and 2-h postload glucose is broadly similar to that posed by A1c.14,18”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to glucose measurements, the continuum of risk is continuous: as A1C rises, the diabetes risk rises disproportionately (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“In a systematic review of 44,203 individuals from 16 cohort studies with a follow-up interval averaging 5.6 years (range 2.8 -12 years), those with A1C between 5.5% and 6.0% (between 37 and 42 mmol/mol) had a substantially increased risk of diabetes (5-year incidence from 9% to 25%).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575 · cited 1×
“The progression of risk of diabetes with A1C is similar in magnitude and shape as previously described for fasting plasma glucose and 2-h glucose and suggests that A1C may have a similar application as an indicator of future risk (27).”
BackgroundRelationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
Background
Research works printed but not linked: 1
- Clarke, 2001, Cochrane Reviewers Handbook
Cited by
Items 101–200 of 422
Yahyavi, S. K., Snorgaard, O., Knop, F. K., Schou, M., Lee, C., Selmer, C., Gislason, G., Torp-Pedersen, C. T., Jensen, M. B., & Bonde, A. N. (2021) · Diabetes Care · doi:10.2337/dc21-1062 · Cited by 40
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 50
Urpí-Sardà, M., Almanza‐Aguilera, E., Tulipani, S., Tinahones, F. J., Salas‐Salvadó, J., & Andrés‐Lacueva, C. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0440-y · Cited by 33
Kim, C., Kim, H., Kim, E., Bae, S., Choe, J., & Park, J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.009 · Cited by 211
Classification and Diagnosis of Diabetes Mellitus
Dennedy, M. C., Rizza, R. A., & Dinneen, S. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00038-x · Cited by 29
Cai, L., Wang, S., Gao, P., Shen, X., Jalaludin, B. B., Bloom, M. S., Wang, Q., Bao, J., Zeng, X., Gui, Z., et al. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108541 · Cited by 29
Hrubeniuk, T. J., Bouchard, D. R., Goulet, E. D. B., Gurd, B., & Sénéchal, M. (2020) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.13567 · Cited by 26
Sass, M. R., Klausen, M. K., Schwarz, C. R., Rasmussen, L., Giver, M. E. B., Hviid, M., Schilling, C., Zamorski, A., Jensen, A., Gefke, M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.3639 · Cited by 43
Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts
Leong, A., Daya, N. R., Porneala, B., Devlin, J. J., Shiffman, D., McPhaul, M. J., Selvin, E., & Meigs, J. B. (2017) · Diabetes Care · doi:10.2337/dc17-0607 · Cited by 28
Барбараш, О. Л., Voyevoda, M. I., Galstyan, G. R., Shestakova, M. V., Boytsov, S. A., Aleksandrova, O. Y., Брызгалина, С. М., Друк, И. В., Каретникова, В. Н., Кашталап, В. В., et al. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-4-83-91 · Cited by 32
Anti-diabetic effects of blue honeyberry on high-fed-diet-induced type II diabetic mouse
Sharma, A., Kim, J. W., Ku, S., Choi, J., & Lee, H. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.5.367 · Cited by 28
“Furthermore, for diabetic patients, an adjustment of drugs or dosages is based on a regular evaluation of the HbA1c levels [50].”
BackgroundPascale, M., Murray, N. J., Bachmann, M. O., Barton, G., Clark, A., Howe, A. C., Greaves, C. J., & Sampson, M. (2017) · BMC Public Health · doi:10.1186/s12889-016-3929-5 · Cited by 31
Booth, R. A., Jiang, Y., MORRISON, H. I., Orpana, H., Katwyk, S. R. V., & Lemieux, C. L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.035 · Cited by 25
Spurr, S., Bally, J. M. G., Bullin, C., Allan, D. E., & McNair, E. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1924-6 · Cited by 26
HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
Soulimane, S., Simon, D., Shaw, J. E., Witte, D. R., Zimmet, P., Vol, S., Borch‐Johnsen, K., Magliano, D. J., Vistisen, D., & Balkau, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.06.003 · Cited by 28
“was a relationship between HbA1c and incident diabetes for HbA1c values from 5% [23] and Nakagami et al.”
BackgroundThe Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis
Bianco, A., CHIEFARI, E. D., Nobile, C. G. A., FOTI, D. P., Pavía, M., & Brunetti, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136077 · Cited by 24
Kullgren, J. T., Knaus, M., Jenkins, K. R., & Heisler, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000212 · Cited by 25
Costa, B., Barrio, F., Cabré, J.-J., Piñol, J. L., Cos, F.-X., Solé, C., Bolíbar, B., Castell, C., Lindström, J., Barengo, N. C., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03304.x · Cited by 25
Glucose control in diabetes: which target level to aim for?
Laakso, M., & Cederberg, H. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02528.x · Cited by 29
Who Should We Target for Diabetes Prevention and Diabetes Risk Reduction?
Blüher, S., Markert, J., Herget, S., Yates, T. E., Davis, M. J., Müller, G., Waldow, T., & Schwarz, P. E. H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0255-x · Cited by 28
Bennasar‐Veny, M., Malih, N., Galmes-Panades, A. M., Hernandez-Bermudez, I. C., García-Coll, N., Ricci‐Cabello, I., & Yáñez, A. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1233312 · Cited by 34
“Lifestyle modi fi cations, including regular physical activity (PA), play a crucial role in preventing the progression to T2D and even reversing prediabetes to normoglycemia (6, 14, 15).”
BackgroundPerez, A., Alos, V. A., Scanlan, A. B., Maia, C. M., Davey, A., Whitaker, R. C., Foster, G. D., Ackermann, R. T., & O’Brien, M. J. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.10.011 · Cited by 25
“Previous research has reported that 25 to 50% of individuals with prediabetes will develop type 2 diabetes within 5 years [2].”
Non-drug interventions of traditional Chinese medicine in preventing type 2 diabetes: a review
Liu, J., Yao, C., Wang, Y., Zhao, J., & Luo, H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00854-1 · Cited by 24
Metformin for overweight women at midlife: a double-blind, randomized, controlled trial
Worsley, R., Jane, F., Robinson, P. J., Bell, R. J., & Davis, S. R. (2014) · Climacteric · doi:10.3109/13697137.2014.954997 · Cited by 23
López, L. V., González–Figueroa, E., Medina‐Bravo, P., Aguila, I. P.-D., Ávila-Jiménez, L., Ramos-Hernández, R. I., Klünder‐Klünder, M., & Escobedo, J. (2012) · Endocrine · doi:10.1007/s12020-012-9775-z · Cited by 29
Kuo, C., Lu, Y., Hsu, C., Chang, C. C., Chou, R., Liu, L.-K., Chen, L., Huang, P., Chen, J., & Lin, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27795-2 · Cited by 23
Lin, J., Zhao, D., Liang, Y., Liang, Z., Wang, M., Tang, X., Zhuang, H., Wang, H., Yin, X., Huang, Y., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06919-9 · Cited by 25
“Gestational diabetes mellitus (GDM) is a common pregnancy complication that refers to spontaneous hyperglycemia during pregnancy [1–3].”
BackgroundThe Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
Lian, H., Wu, H., Ning, J., Lin, D., Huang, C., Li, F., Liang, Y. J., Qi, Y., Ren, M., Yan, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673976 · Cited by 26
Barbu, E. M., Popescu, M. R., Popescu, A.-C., & Balanescu, S. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136864 · Cited by 27
“When establishing the HbA1c cut-off for the diagnosis of prediabetes, expert committees had to rely on information about the shape of risk curves for complications such as retinopathy in the absence of clinical trials that determine the exact moment when the intervention results in the delay of diabetes and its compli…”
MethodShahid, R. K., Chu, L. M., Arnason, T., & Pahwa, P. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.03.006 · Cited by 23
Real Incidence of Diabetes Mellitus in a Coronary Disease Population
de la Hera, J. M., García-Ruiz, J. M., Martínez‐Camblor, P., Martín, M. A. A., Tellería, A. L., Corros, C., Torres, F., Fernández-Cimadevilla, O. C., Pichel, I. A., Capín, E., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.008 · Cited by 20
Huang, J., Yu, M., Huang, C., Juo, S. H., Dai, C., Hsieh, M., Hou, N., Yeh, M., Hsieh, M., Yang, J., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02771.x · Cited by 20
“relatively high risk for future development of DM and even dyslipidemia and cardiovascular disease (15).”
BackgroundYang, J., & Jiang, S. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s363474 · Cited by 22
“Elevated serum glycated hemoglobin predicts the progression of diabetes, and many prospective studies have reported a close relationship between HbA1c and diabetic complications.(42,43) HbA1c initiates the expression of inflammatory factors,(44) promotes oxidative stress through ROS production, induces apoptosis, and…”
BackgroundKhan, H. A., Ola, M. S., Alhomida, A. S., Sobki, S. H., & Khan, S. A. (2013) · Endocrine Research · doi:10.3109/07435800.2013.828740 · Cited by 25
“5% has been found to be associated with a highly increased risk of diabetes, 25–50% incidence over 5 years (9).”
BackgroundHemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels
Marini, M. A., Fiorentino, T. V., Andreozzi, F., Mannino, G. C., Succurro, E., Sciacqua, A., Perticone, F., & Sesti, G. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.001 · Cited by 25
“Measurement of HbA1c has been recently recommended by ADA as a diagnostic test not 197 only for diabetes but also for conditions at increa sed risk to develop diabetes [1,3-5].”
Iser, B. P. M., Pinheiro, P. C., Malta, D. C., Duncan, B. B., & Schmidt, M. I. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021262.34852020 · Cited by 20
Nakano, H., Shiina, K., Takahashi, T., Fujii, M., Iwasaki, Y., Matsumoto, C., Yamashina, A., Chikamori, T., & Tomiyama, H. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.025924 · Cited by 22
Gottwald‐Hostalek, U., & Gwilt, M. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2101805 · Cited by 22
Using Peer Support to Prevent Diabetes: Results of a Pragmatic RCT
Heisler, M., Dyer, W. T., Finertie, H., STOLL, S. C., Wiley, D. M., Turner, C. D., Sedgwick, T., Kullgren, J. T., Richardson, C. R., Hedderson, M. M., et al. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.02.015 · Cited by 23
Sakamoto, K., Kubo, F., Yoshiuchi, K., Ono, A., Sato, T., Tomita, K., Sakaguchi, K., Matsuhisa, M., Kaneto, H., Maegawa, H., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12096 · Cited by 21
Pan, L. Y., Liu, S., Dai, G., Lei, Y., & Liang, Y. (2013) · Australian Journal of Chemistry · doi:10.1071/ch13102 · Cited by 19
Sohler, N., Matti‐Orozco, B., Young, E., Li, X., Gregg, E. W., Ali, M. K., Bullard, K. M., & Albu, J. (2015) · Endocrine Practice · doi:10.4158/ep15866.or · Cited by 23
Self-citationRiesgo de pie diabético y déficit de autocuidados en pacientes con Diabetes Mellitus Tipo 2
Fernández, I. C., & Prieto, J. M. R. (2018) · Enfermería Universitaria · doi:10.22201/eneo.23958421e.2018.1.62902 · Cited by 47
Childhood obesity: an overview of laboratory medicine, exercise and microbiome
Scudiero, O., Pero, R., Ranieri, A., Terracciano, D., Fimiani, F., Cesaro, A., Gentile, L., Leggiero, E., Laneri, S., Moscarella, E., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0789 · Cited by 33
“In IR, the body can produce insulin but the muscle, fat and liver do not respond appropriately and thus cannot easily absorb glucose from the bloodstream, with progression from IR to prediabetes with impaired glucose tolerance (IGT) and impaired fasting glucose over time [73].”
BackgroundSun, M., Sun, X., Fei, W., & Liu, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1614657 · Cited by 28
Chilelli, N. C., Cosma, C., Ragazzi, E., Burlina, S., Zaninotto, M., Plebani, M., & Lapolla, A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0639-2 · Cited by 18
“4 % (39–46 mmol/mol) have a higher risk of developing future diabetes, with a 5-year incidence of 10–50 % [24, 25].”
BackgroundSepers, C. E., Fawcett, S. B., Lipman, R. D., Schultz, J. A., Collie-Akers, V. L., & Pérez, A. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715577638 · Cited by 23
“Further, an estimated 79 million adults are prediabetic with as many as 9–50% developing overt diabetes during their lifetime (Zhang et al., 2010).”
BackgroundSoo, D. H. E., Pendharkar, S. A., Jivanji, C. J., Gillies, N. A., Windsor, J. A., & Petrov, M. S. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.05.021 · Cited by 18
Lizarzaburu-Robles, J. C., Herman, W. H., Garro-Mendiola, A., Sanz-Pastor, A. G., & Lorenzo, Ó. (2024) · Biomedicines · doi:10.3390/biomedicines12020363 · Cited by 19
“The principal limitation of the study was the lack of original data to model the continuous association between HbA1c values and diabetes incidence [39].”
Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity
Hoe, F. M., Darbinian, J. A., Greenspan, L. C., & Lo, J. C.-M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.51322 · Cited by 20
Issues in Defining the Burden of Prediabetes Globally
Echouffo-Tcheugui, J. B., Kengne, A. P., & Ali, M. K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1089-y · Cited by 19
Alzeidan, R. A., Shata, Z. N., Hassounah, M. M., Baghdadi, L. R., Hersi, A. S., Fayed, A. A., Kashour, T. S., & Elmorshedy, H. (2019) · BMC Public Health · doi:10.1186/s12889-019-7921-8 · Cited by 23
Kousignian, I., Sautereau, A., Vigouroux, C., Cros, A., Kretz, S., Viard, J. P., & Slama, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250676 · Cited by 17
“Despite the fact that HbA1c may underestimate FG in PLWH [40–42], our results, supported by other studies [43,44], suggest that HbA1c, in addition to FG or a 2-hour OGTT could be useful for the diagnosis of DM in PLWH.”
ResultRodacki, M., Zajdenverg, L., Júnior, W. S. D. S., Giacaglia, L. R., Negrato, C. A., Cobas, R. A., de Almeida-Pititto, B., & Bertoluci, M. C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01572-w · Cited by 25
Miller, E. M., & Miller, K. (2024) · Clinical Diabetes · doi:10.2337/cd23-0077 · Cited by 18
“An estimated 25 – 50% of individuals with an A1C of 6.0 – 6.5% (42 – 48 mmol/mol) will progress to clinical type 2 diabetes within 5 years (27).”
BackgroundInfluentialMo, M., Zhong, W., Zhao, G., Ruan, Y., Zhang, H., Shi, L., Lu, D., Yang, Q., Li, Y., Jiang, Q., et al. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-44 · Cited by 16
“5%) have been associated with a substantially increased risk for developing T2DM [13].”
BackgroundAliarzadeh, B., Greiver, M., Moineddin, R., Meaney, C. A., White, D., Moazzam, A., Moore, K. M., & Bélanger, P. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-7 · Cited by 16
“Increasing levels of Hgb A1c are strongly associated with greater risk of incident diabetes; Hgb A1c levels of 6% or more lead to a five year risk of diabetes ranging from 25% to 50% [6].”
BackgroundAngosta, A. D., & Speck, K. E. (2014) · Clinical Nursing Studies · doi:10.5430/cns.v2n2p123 · Cited by 16
Chen, C.-L., Yen, D. H. T., Lin, C., Tsai, S., Chen, S., Sheu, W. H., & Hsu, C.-W. (2017) · Medicine · doi:10.1097/md.0000000000006743 · Cited by 22
Atkin, S. L., Butler, A. E., Hunt, S. C., & Kilpatrick, E. S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14449 · Cited by 20
Almari, M., Al-Saedi, S. A., Mohammad, A., & Ziyab, A. H. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12780 · Cited by 15
“range between 5% and 10%; whereas, the lifetime incidence rate may reach 70%.(1,11,12) Prediabetes, therefore, is a silent epidemic that is rapidly emerging among youth with substantial adverse health effects.”
BackgroundPrediabetes: An emerging public health concern in adolescents
Spurr, S., Bally, J. M. G., Allan, D. E., Bullin, C., & McNair, E. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.60 · Cited by 16
Reproducibility of a prediabetes classification in a contemporary population
Chadha, C., Pittas, A. G., Lary, C. W., Knowler, W. C., Chatterjee, R., Phillips, L. S., Aroda, V. R., Lewis, M. R., Pratley, R., Staten, M. A., et al. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100031 · Cited by 15
“Our results confirm that the prediabetes classification includes a continuum of risk for diabetes that rises as FPG and HbA1c values increase within the prediabetes range [10].”
ResultAnti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice
Zhou, A. Y., Taylor, B. E., Barber, K. G., Lee, C. A., Taylor, Z. R. R., Howell, S. J., & Taylor, P. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021347 · Cited by 17
“Per the American Diabetes Association, a hemoglobin A1C percentage (A1C) is a very reliable way to determine if an individual is diabetic, pre-diabetic, or non-diabetic [22].”
BackgroundZuk, A. M., Quiñonez, C., Lebenbaum, M., & Rosella, L. C. (2016) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12684 · Cited by 21
Identifying prediabetes – Is it beneficial in the long run?
Ghody, P., Shikha, D., Karam, J., & Bahtiyar, G. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.03.022 · Cited by 18
Patel, M. S., Polsky, D. E., Small, D. S., Park, S.-H., Evans, C. N., Harrington, T. O., DJARAHER, R. L., Changolkar, S., Snider, C. K., & Volpp, K. G. M. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00541-1 · Cited by 17
Baek, Y., Kim, M.-S., Kim, G. R., & Park, E. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033579 · Cited by 13
Goyal, A., Gupta, Y., Kubihal, S., Kalaivani, M., Bhatla, N., & Tandon, N. (2021) · Advances in Therapy · doi:10.1007/s12325-020-01618-1 · Cited by 16
Implications of Risk Stratification for Diabetes Prevention
Gregg, E. W., Geiss, L. S., Zhang, P., Zhuo, X., Williamson, D. F., & Albright, A. L. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.012 · Cited by 16
Self-citationNeves, L. M. G., Matheus, R. L., dos Santos, G. M. T., Esquisatto, M. A. M., do Amaral, M. E. C., & Mendonça, F. A. S. (2013) · Laser Physics · doi:10.1088/1054-660x/23/3/035604 · Cited by 16
Comparison of IFCC-calibrated HbA1c from laboratory and point of care testing systems
Manley, S. E., Hikin, L., ROUND, R. A., Manning, P. W., Luzio, S. D., Dunseath, G. J., Nightingale, P., STRATTON, I. M., Cramb, R., Sikaris, K. A., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.003 · Cited by 18
McCoy, R. G., Nori, V. S., Smith, S. A., & Hane, C. A. (2016) · Health Services Research · doi:10.1111/1475-6773.12461 · Cited by 14
“The observed rates of incident diabetes in risk strata predicted byHealthImpact are comparable to those using laboratory-based criteria (Zhang et al. 2010; Ackermann et al. 2011).”
ResultType 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics
Leong, A., & Meigs, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.351 · Cited by 15
Washirasaksiri, C., Srivanichakorn, W., Borrisut, N., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Ariyakunaphan, P., Auesomwang, C., Sayabovorn, N., Chaisathaphol, T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950225 · Cited by 17
“(Gerstein et al., 2007; Zhang et al., 2010; Echouffo-Tcheugui and Selvin, 2021) This finding is consistent with a meta-analysis of prospective cohort studies that showed that individuals with the combination of more than one indicator of prediabetes (IFG+/IGT+) had the highest risk of developing diabetes.”
BackgroundResultHaines, M. R. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00571-8 · Cited by 14
Barbot, M., Regazzo, D., Mondin, A., Zilio, M., Lizzul, L., Zaninotto, M., Plebani, M., Arnaldi, G., Ceccato, F., & Scaroni, C. M. (2020) · Pituitary · doi:10.1007/s11102-020-01055-x · Cited by 15
Joiner, K. L., McEwen, L. N., Hurst, T. E., Adams, M. P., & Herman, W. H. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108220 · Cited by 21
Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study
Fikri‐Benbrahim, N., Martínez‐Martínez, F., Sáez‐Benito, L., Luque, B. S., Corpas, J. P. G., Moullin, J. C., & Sabater‐Hernández, D. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.03.006 · Cited by 13
Naya, L. D., & Delgado, E. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.001 · Cited by 70
Recalde, J. F. C., Arroyo, J. R. R., & García-Blanco, F. R. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.11.007 · Cited by 14
Biological diagnosis of diabetes mellitus
Zendjabil, M. (2015) · Current Research in Translational Medicine · doi:10.1016/j.patbio.2015.10.002 · Cited by 18
Prediabetes, Non-Dipping Profile and Hypertension—A Recipe for Increased Arterial Stiffness
Jug, J., Delalić, Đ., Lang, V. B., Bulum, T., & Prkačin, I. (2023) · Biomedicines · doi:10.3390/biomedicines11041065 · Cited by 13
“Knowing that 9 to 50% of persons with PreD will develop T2DM in five years and 70% in ten years, the CV risk will additionally increase, because of which we have to start treating PreD and all CV risk factors immediately [32,33].”
BackgroundThe Impact of Prediabetes on Glycemic Control and Clinical Outcomes Postburn Injury
Somerset, A. E., Coffey, R., Jones, L. M., & Murphy, C. V. (2013) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3182a2adea · Cited by 12
An Introduction to Redox Balance and Lipid Oxidation
Spickett, C. M., Fedorova, M., Hoffmann, R., & Forman, H. J. (2015) · Oxidative stress and disease · doi:10.1201/b18138-2 · Cited by 15
Kato, M., Noda, M., Suga, H., Nakamura, T., Matsumoto, M., Kanazawa, Y., & for the Omiya MA Cohort Study Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03572.x · Cited by 11
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C
Marini, M. A., Frontoni, S., Succurro, E., Arturi, F., Sciacqua, A., Hribal, M. L., Perticone, F., & Sesti, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.01.011 · Cited by 13
“0% have an increased risk of diabetes with 5-year incidences ranging from 9 to 25% [4].”
BackgroundMethodSiwik, V. P., Kutob, R. M., Ritenbaugh, C., Aickin, M. G., & Gordon, J. S. (2012) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721712461533 · Cited by 12
“People with prediabetes may have up to 20 times higher risk of developing diabetes than those with normal hemoglobin A1C values.(7) Prediabetes is also one of several indicators of metabolic syndrome, along with hypertension, dyslipidemia, and increased adiposity.”
BackgroundAoki, Y., Sofue, T., Kawakami, R., Ozaki, T., Manabe, M., Kanda, K., Yoda, T., Kusaka, T., Hirao, T., & Minamino, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-19724-1 · Cited by 11
Diagnostic Criteria and Classification of Diabetes
Leu, J. P., & Zonszein, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_7 · Cited by 20
Alam, M. N. U., Hasnine, I., Bahadur, E. H., Masum, A. K. M., Urbano, M. B., Vergara, M. M., Uddin, J., Ashraf, I., & Samad, M. A. (2024) · Journal Of Big Data · doi:10.1186/s40537-024-00959-w · Cited by 11
“A1C level ≥ 6.5% indicates that the individual has diabetes [75–77].”
BackgroundInfluentialSíndrome Metabólica em Portugal: Prevalência e Fatores Associados
Alves, R. C., Santos, A. J., Kislaya, I., Nunes, B., & Freire, A. C. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.15051 · Cited by 20
Fatouhi, D. E., Héritier, H., Allémann, C., Malisoux, L., Laouali, N., Riveline, J., Salathé, M., & Fagherazzi, G. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0294 · Cited by 15
Perspectives on Prediabetes and Aging
Al‐Sofiani, M. E., Asiri, A. A., Alajmi, S., & Alkeridy, W. A. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.011 · Cited by 11
Cost-effectiveness analysis of a digital Diabetes Prevention Program (dDPP) in prediabetic patients
Park, S., Ward, T., Sudimack, A., Cox, S., & Ballreich, J. M. (2023) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x231174262 · Cited by 10
“23 Research has shown that despite the effectiveness of traditional DPPs validated across diverse settings and populations, access to these services is limited.”
Risk Factors for Progression to Type 2 Diabetes in a Pediatric Prediabetes Clinic Population
Belsky, N. A., Tamaroff, J. G., & Shoemaker, A. H. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad118 · Cited by 14
“Prediabetes diagnostic criteria were derived from adult definitions based on long-term health outcomes and clinical trials in populations aged older than 18 years [7, 8].”
MethodLo, H., Hsiang, C., Li, T., Li, C., Huang, H., Chen, J., & Ho, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104650 · Cited by 10
“Moreover, a regular assessment of HbA1c level in diabetic patients allows the adjustment of patients’ drugs or dosages [7,8].”
Lee, S., Ay, C., Kopp, C. W., Panzer, S., & Gremmel, T. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0774-0 · Cited by 11
Wang, D., Wang, Y., Madhu, S., Liang, H., & Bray, C. L. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.01.002 · Cited by 12
Identification of MODY among patients screened for gestational diabetes: a clinician’s guide
Urbanová, J., Brunerová, L., Nunes, M. A., & Brož, J. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05626-y · Cited by 11
“1 3 glycated hemoglobin (HbA1c) in women with recently diagnosed GDM [5], as its high level (indicating more severe disorder of glucose metabolism) can point at diabetes presented even before conception [6, 7].”
Background
Metadata
- Authors
- Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Corresponding author
- Zhang, Xuanping
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1665-1673
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890379
- OpenAlex
- W2137837290
- Cited by
- 422
- References
- 32
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 30 · 2023: 34 · 2022: 28 · 2021: 34 · 2020: 22 · 2019: 22 · 2018: 22 · 2017: 27 · 2016: 27 · 2015: 29 · 2014: 26 · 2013: 29 · 2012: 24
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- HbA1c, new-onset diabetes, diabetes risk prediction, prediabetes, diabetes prevention, HbA1c thresholds, diabetes incidence
- MeSH terms
- Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

